CONMED (NYSE:CNMD) PT Lowered to $71.00 at Wells Fargo & Company

CONMED (NYSE:CNMD – Free Report) had its target price cut by Wells Fargo & Company from $77.00 to $71.00 in a research note published on Thursday morning, Benzinga reports. They currently have an equal weight rating on the stock. Other research analysts have also issued reports about the stock. JPMorgan Chase & Co. decreased their […]

Leave a Reply

Your email address will not be published.

Previous post The Cigna Group (NYSE:CI) PT Raised to $405.00
Next post Telsey Advisory Group Reaffirms “Outperform” Rating for Traeger (NYSE:COOK)